GL1X · GenesisL1 explorer

Research workbench

A new HIV fusion peptide inhibitor

Analyse A new HIV fusion peptide inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5BN0
Type
protein
Length
211 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Envelope glycoprotein GP160; Envelope glycoprotein
UniProt
B2CPZ5, Q1HMR5
Ligands
ACE

Structure

x-ray diffraction · 5 distinct chains · 91% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
C, AEnvelope glycoprotein GP160protein3686% helix, 0% strandB2CPZ5
NEnvelope glycoproteinprotein3494% helix, 0% strandQ1HMR5
BEnvelope glycoproteinprotein3594% helix, 0% strandQ1HMR5
DEnvelope glycoprotein GP160protein3491% helix, 0% strandB2CPZ5
EEnvelope glycoproteinprotein3692% helix, 0% strandQ1HMR5

Ligands and binding sites

  • ACE · Acetyl group · ligand · 2 copies · chains C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

9 interfaces between chains.

  • C–N · 873 Ų buried · 9 hydrogen bonds · protein-protein
  • D–E · 811 Ų buried · 9 hydrogen bonds · protein-protein
  • A–B · 773 Ų buried · 6 hydrogen bonds · protein-protein
  • B–E · 678 Ų buried · 4 hydrogen bonds · protein-protein
  • N–B · 666 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 5BN0 · A new HIV fusion peptide inhibitor · the same entry in another collection · chain C against C, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.